XML 17 R4.htm IDEA: XBRL DOCUMENT v3.6.0.2
Consolidated Statements of Income and Comprehensive Income - USD ($)
 12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Revenues $ 82,460,000 $ 76,427,000
Cost of Products Sold 57,352,000 53,111,000
Gross Profit 25,108,000 23,316,000
Operating Expenses:    
Research and Development 5,946,000 5,603,000
Selling, General and Administrative 15,399,000 14,233,000
Intangible Asset Impairment 0 150,000
Total Operating Expenses 21,345,000 19,986,000
Operating Income 3,763,000 3,330,000
Other (Expense) Income:    
Interest Income 0 3,000
Interest and Financing Expense (263,000) (248,000)
Miscellaneous 80,000 65,000
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3,580,000 3,150,000
Income Tax Provision 98,000 310,000
Net income 3,482,000 2,840,000
Net Loss Attributable to Non-Controlling Interest 27,000 29,000
Net Income Attributable to Ultralife Corporation 3,509,000 2,869,000
Other Comprehensive Loss:    
Foreign Currency Translation Adjustments (2,173,000) (440,000)
Comprehensive Income Attributable to Ultralife Corporation $ 1,336,000 $ 2,429,000
Net Income Per Share Attributable to Ultralife Corporation Common Shareholders – Basic: (in dollars per share) $ 0.23 $ 0.18
Net Income Per Share Attributable to Ultralife Corporation Common Shareholders – Diluted: (in dollars per share) $ 0.23 $ 0.17
Weighted Average Shares Outstanding – Basic (in shares) 15,261 16,182
Weighted Average Shares Outstanding – Diluted (in shares) 15,405 16,458